Research Paper Volume 13, Issue 6 pp 8737—8761
Downregulation of FPN1 acts as a prognostic biomarker associated with immune infiltration in lung cancer
Figure 7. GSEA of FPN1 in lung cancer. (A, B) Merged plots were constructed to exhibit the enriched pathways correlated with FPN1 in LUAD according to GO and KEGG analyses. (C, D) Merged plots were constructed to exhibit the enriched pathways correlated with FPN1 in LUSC according to GO and KEGG analyses.